Skip to main content
. 2017 Oct 30;7(2):e1386827. doi: 10.1080/2162402X.2017.1386827

Table 2.

Clinical Outcomes: Summary of responses and survival. NED = No Evident Disease by examination and chest x- ray for at least 8 weeks followed by negative scans. The table provides median and range of data on all 87 patients for: time to NED, the % of patients achieving NED for greater than 2 months, and the % of patients with a cumulative duration of NED of 2, 3 and 5 years. The table also presents median and range of overall and disease-free survival from entry at different times. Because some patients relapsed after being free of disease for protracted periods, the % of subjects surviving free of disease for 1 to 5 years after entry is less than the cumulative duration of disease free periods. Also a few disease-free patients were lost to follow up.

Melanoma Clinical Outcomes: Summary Tables
  Time to
  NED Duration in months
       
Frequency and durability of responses
Median
Range
% all pts
Median
Range
NED 1 yr
NED 2 yr
NED 3 yr
NED ≥ 5 yr
At least 2 completely regressed met 4 mo 0–46 72%            
NED >2 months (CR) 15 0–48 38% 59 2–334 31% 28% 24% 20%
NED when last seen     25% 100 6–348        
57 pts (66%) reached stage IV     11% of stage IV 100 5–334        
        Survival in months
       
Survival
 
 
 
Median
Range
Surv 1 yr
Surv 2 yr
Surv 3 yr
Surv ≥ 5 yr
All pts overall survival from entry       28.5 4–348 70% 54% 43% 29%
All pts survival from entry, disease free     25% 100 6–348 23% 23% 23% 20%
Progres. dis. 54 pts, never NED : survival to death or chemo       18 3 to 75 56% 30% 20% 9%